Antibiotic resistance of Acinetobacter baumannii in Iran: A systemic review of the published literature

Osong Public Health and Research Perspectives

Volumn 6, Issue 2, 2015, Pages 79-86

  Moradi, Jale ^a   Hashemi, Farhad B ^a   Bahador, Abbas ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acinetobacter baumannii; Antibiotic resistance; Iran

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; CARBAPENEM DERIVATIVE; IMIPENEM; MEROPENEM; POLYPEPTIDE ANTIBIOTIC AGENT;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; DATA ANALYSIS; GENOTYPE; IRAN; MEDICAL LITERATURE; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TREND STUDY;

EID: 84928581654     PISSN: 22109099     EISSN: 22336052     Source Type: Journal    
DOI: 10.1016/j.phrp.2014.12.006     Document Type: Article

References (54)

1. Chittawatanarat K., Jaipakdee W., Chotirosniramit N., et al. Microbiology, resistance patterns, and risk factors of mortality in ventilator-associated bacterial pneumonia in a Northern Thai tertiary-care university based general surgical intensive care unit. Infect Drug Resist 2014, 7:203-210.
2. Eveillard M., Kempf M., Belmonte O., et al. Reservoirs of Acinetobacter baumannii outside the hospital and potential involvement in emerging human community-acquired infections. Int J Infect Dis 2013, 17(10):802-805.
3. Oh Y.J., Song S.H., Baik S.H., et al. A case of fulminant community-acquired Acinetobacter baumannii pneumonia in Korea. Korean J Intern Med 2013, 28(4):486-490.
4. Kim U.J., Kim H.K., An J.H., et al. Update on the epidemiology, treatment, and outcomes of carbapenem-resistant Acinetobacter infections. Chonnam Med J 2014 Aug, 50(2):37-44.
5. Tang S.S., Apisarnthanarak A., Hsu L.Y. Mechanisms of β-lactam antimicrobial resistance and epidemiology of major community- and healthcare-associated multidrug-resistant bacteria. Adv Drug Deliv Rev 2014 Nov, 78:3-13.
6. Nhu N.T., Lan N.P., Campbell J.I., et al. Emergence of carbapenem-resistant Acinetobacter baumannii as the major cause of ventilator-associated pneumonia in intensive care unit patients at an infectious disease hospital in southern Vietnam. J Med Microbiol 2014 Oct, 63(10):1386-1394.
7. Liu B., Liu Y., Di X., et al. Colistin and anti-Gram-positive bacterial agents against Acinetobacter baumannii. Rev Soc Bras Med Trop 2014 Jul, 47(4):451-456.
8. García-Quintanilla M., Pulido M.R., López-Rojas R., et al. Emerging therapies for multidrug resistant Acinetobacter baumannii. Trends Microbiol 2013, 21:157-163.
9. Antunes L.C., Visca P., Towner K.J. Acinetobacter baumannii: evolution of a global pathogen. Pathog Dis 2014 Aug, 71(3):292-301.
10. Feizabadi M.M., Fathollahzadeh B., Taherikalani M., et al. Antimicrobial susceptibility patterns and distribution of blaOXA genes among Acinetobacter spp. Isolated from patients at Tehran hospitals. Jpn J Infect Dis 2008, 61:274-278.
11. Soroush S., Haghi-Ashtiani M.T., Taheri-Kalani M., et al. Antimicrobial resistance of nosocomial strain of Acinetobacter baumannii in Children's Medical Center of Tehran: a 6-year prospective study. Acta Med Iranica 2010, 48:178-184.
12. Taherikalani M., Maleki A., Sadeghifard N., et al. Dissemination of class 1, 2 and 3 integrons among different multidrug resistant isolates of Acinetobacter baumannii in Tehran hospitals, Iran. Pol J Microbiol 2011, 60:169-174.
13. Bahador A., Raoofian R., Taheri M., et al. Multidrug resistance among Acinetobacter Baumannii isolates from Iran: Changes in antimicrobial susceptibility patterns and genotypic profile. Microb Drug Resist 2014 Dec, 20(6):632-640.
14. Japoni S., Japoni A., Farshad S., et al. Association between existence of integrons and multi-drug resistance in Acinetobacter isolated from patients in southern Iran. Pol J Microbiol 2011, 60(2):163-168.
15. Mohammadi-Mehr M., Feizabadi M.M. Antimicrobial resistance pattern of Gram-negative bacilli isolated from patients at ICUs of Army hospitals in Iran. Iran J Microbiol 2011, 3:26-30.
16. Moniri R., Farahani R.K., Shajari G., et al. Molecular epidemiology of aminoglycosides resistance in Acinetobacter spp. With emergence of multidrug-resistant strains. Iran J Public Health 2010, 39(2):63-68.
17. Sarafzadeh F., Sohrevardi S., Gharehghozli M., et al. Detection of the most common microorganisms and their resistance against anti-microbials in intubated patients in an ICU in Kerman, Iran. Iran J Pharm Res 2010 Fall, 9(4):437-443.
18. Peymani A., Nahaei M.R., Farajnia S., et al. High prevalence of metallo-beta-lactamase-producing Acinetobacter baumannii in a teaching hospital in Tabriz. Iran. Jpn J Infect Dis 2011, 64:69-71.
19. Peymani A., Farajnia S., Nahaei M.R., et al. Prevalence of class 1 integron among multidrug-resistant Acinetobacter baumannii in Tabriz, northwest of Iran. Pol J Microbiol 2012, 61:57-60.
20. Sohrabi N., Farajnia S., Akhi M.T., et al. Prevalence of OXA-type beta-lactamases among Acinetobacter baumannii isolates from Northwest of Iran. Microb Drug Resist 2012, 18(1):385-389.
21. Farajnia S., Azhari F., Alikhani M.Y., et al. Prevalence of PER and VEB type extended spectrum betalactamases among multidrug resistant Acinetobacter baumannii isolates in North-West of Iran. Iran J Basic Med Sci 2013 Jun, 16:751-755.
22. Shahcheraghi F., Abbasalipour M., Feizabadi M.M., et al. Isolation and genetic characterization of metallo-beta-lactamase and carbapenamase producing strains of Acinetobacter baumannii from patients at Tehran hospitals. Iran J Microbiol 2011 June, 3(2):68-74.
23. Asadollahi P., Akbari M., Soroush S., et al. Antimicrobial resistance patterns and their encoding genes among Acinetobacter baumannii strains isolated from burned patients. Burns 2012 Dec, 38(8):1198-1203.
24. Mirnejad R., Mostofi S., Masjedian F. Antibiotic resistance and carriage class 1 and 2 integrons in clinical isolates of Acinetobacter baumannii from Tehran, Iran. Asian Pac J Trop Biomed 2013 Feb, 3(2):140-145.
25. Owlia P., Azimi L., Gholami A., et al. ESBL- and MBL-mediated resistance in Acinetobacter baumannii: a global threat to burn patients. Infez Med 2012 Sep, 20(3):182-187.
26. Shakibaie M.R., Adeli S., Salehi M.H. Antibiotic resistance patterns and extended-spectrum beta-lactamase production among Acinetobacter spp. isolated from an intensive care Unit of a hospital in Kerman, Iran. Antimicrob Resist Infect Control 2012 Jan 26, 1(1):1.
27. Rezaee M.A., Pajand O., Nahaei M.R., et al. Prevalence of Ambler class a beta-lactamases and ampC expression in cephalosporin-resistant isolates of Acinetobacter baumannii. Diagn Micr Infec Dis 2013 Jul, 76(3):330-334.
28. Pajand O., Rezaee M.A., Nahaei M.R., et al. Study of the carbapenem resistance mechanisms in clinical isolates of Acinetobacter baumannii: comparison of burn and non-burn strains. Burns 2013 Nov, 39(7):1414-1419.
29. Aghazadeh M., Rezaee M.A., Nahaei M.R., et al. Dissemination of aminoglycoside-modifying enzymes and 16S rRNA methylases among Acinetobacter baumannii and Pseudomonas aeruginosa isolates. Microb Drug Resist 2013 Aug, 19(4):282-288.
30. Azimi L., Lari A.R., Talebi M., et al. Comparison between phenotypic and PCR for detection of OXA-23 type and metallo-beta-lactamases producer Acinetobacter spp. GMS Hyg Infect Control 2013 Nov, 8(2):16.
31. Japoni-Nejad A., Sofian M., Belkum A., et al. Nosocomial outbreak of extensively and pan drug-resistant Acinetobacter baumannii in tertiary hospital in central part of Iran. Jundishapur J Microbiol 2013, 6:92-98.
32. Japoni-Nejad A., Farshad S., van Belkum A., et al. Novel cassette array in a class 1 integron in clinical isolates of Acinetobacter baumannii from central Iran. Int J Med Microbiol 2013 Dec, 303(8):645-650.
33. Karmostaji A., Peerayeh S.N., Salmanian A.H. Distribution of OXA-type class D β-lactamase genes among nosocomial multi drug resistant Acinetobacter baumannii isolated in Tehran Hospital. Jundishapur J Microbiol 2013, 6:12-14.
34. Mohajeri P., Farahani A., Feizabadi M.M., et al. Antimicrobial susceptibility profiling and genomic diversity of Acinetobacter baumannii isolates: A study in western Iran. Iran J Microbiol 2013 Sep, 5(3):195-202.
35. Hojabri Z., Pajand O., Bonura C., et al. Molecular epidemiology of Acinetobacter baumannii in Iran: endemic and epidemic spread of multiresistant isolates. J Antimicrob Chemother 2014 Sep, 69(9):2383-2387.
36. Maleki M.H., Sekawi Z., Soroush S., et al. Phenotypic and genotypic characteristics of tetracycline resistant Acinetobacter baumannii isolates from nosocomial infections at Tehran hospitals. Iran J Basic Med Sci 2014 Jan, 17(1):21-26.
37. Nowroozi J., Sepahi A.A., Kamarposhti L.T., et al. Evaluation of ciprofloxacin (gyrA, parC genes) and tetracycline (tetB gene) resistance in nosocomial Acinetobacter baumannii infections. Jundishapur J Microbiol 2014 Feb, 7(2):e8976.
38. Mirnejad R., Vafaei S. Antibiotic resistance patterns and the prevalence of ESBLs among strains of Acinetobacter baumannii isolated from clinical specimens. JGMI 2013, 2:1-8.
39. Safari M., Saidijam M., Bahador A., et al. High prevalence of multidrug resistance and metallo-beta-lactamase (MbetaL) producing Acinetobacter baumannii isolated from patients in ICU wards, Hamadan. Iran J Res Health Sci 2013 Sep, 13(2):162-167.
40. Vakili B., Fazeli H., Shoaei P., et al. Detection of colistin sensitivity in clinical isolates of Acinetobacter baumannii in Iran. Iran J Res Med Sci 2014 Mar, 19(Suppl. 1):S67-70.
41. Bahador A., Taheri M., Pourakbari B., et al. Emergence of rifampicin, tigecycline, and colistin-resistant Acinetobacter baumannii in Iran; spreading of MDR strains of novel International Clone variants. Microb Drug Resist 2013 Oct, 19(5):397-406.
42. Kamalbeik S., Talaie H., Mahdavinejad A., et al. Multidrug-resistant Acinetobacter baumannii infection in intensive care unit patients in a hospital with building construction: is there an association?. Korean J Anesthesiol 2014 Apr, 66(4):295-299.
43. Pajand O., Hojabri Z., Nahaei M.R., et al. Invitro activities of tetracyclines against different clones of multidrug-resistant Acinetobacter baumannii isolates from two Iranian hospitals. Int J Antimicrob Agents 2014 May, 43(5):476-478.
44. Fallah F., Noori M., Hashemi A., et al. Prevalence of bla NDM, bla PER, bla VEB, bla IMP, and bla VIM genes among Acinetobacter baumannii isolated from two hospitals of Tehran, Iran. Scientifica (Cairo) 2014, 2014:245162.
45. Falagas M.E., Koletsi P.K., Bliziotis I.A. The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. J Med Microbiol 2006 Dec, 55(Pt 12):1619-1629.
46. Livermore D.M., Hope R., Brick G., et al. BSAC Working Parties on Resistance Surveillance. Non-susceptibility trends among Pseudomonas aeruginosa and other non-fermentative Gram-negative bacteria from bacteremias in the UK and Ireland, 2001-06. J Antimicrob Chemother 2008 Nov, 2(Suppl. 5):55-63.
47. Morgan D.J., Weisenberg S.A., Augenbraun M.H., et al. Multidrug-resistant Acinetobacter baumannii in New York City - 10 years into the epidemic. Infect Control Hosp Epidemiol 2009 Feb, 30(2):196-197.
48. Dijkshoorn L., Aucken H., Gerner-Smidt P., et al. Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods. J Clin Microbiol 1996 Jun, 34(6):1519-1525.
49. Falagas M.E., Kasiakou S.K. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis 2005 May, 40(9):1333-1341.
50. Gounden R., Bamford C., van Zyl-Smit R., et al. Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections. BMC Infect Dis 2009 Mar, 9(9):26-28.
51. Linden P.K., Paterson D.L. Parenteral and inhaled colistin for treatment of ventilator-associated pneumonia. Clin Infect Dis 2006 Sep, 2(Suppl. 2):89-94.
52. Fishbain J., Peleg A.Y. Treatment of Acinetobacter infections. Clin Infect Dis 2010 Jul, 51(1):79-84.
53. Garnacho-Montero J., Amaya-Villar R. Multiresistant Acinetobacter baumannii infections: epidemiology and management. Curr Opin Infect Dis 2010, 23:332-339.
54. Peleg A.Y., Seifert H., Paterson D.L. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008 Jul, 21(3):538-582.